Dr. Goldstein's research encompasses three aims:
1. to identify biomarkers which enhance clinical decision-making for adolescents with bipolar disorder
2. to advance the understanding of shared biological factors underlying the links between bipolar disorder and cardiovascular disease
3. to examine the impact of novel pharmacological and behavioral treatments on psychiatric and cardiovascular outcomes among youth with bipolar disorder.
Goldstein BI, Birmaher B, Axelson DA, Goldstein TR, Esposito-Smythers C, Strober MA, Hunt J, Leonard H, Gill MK, Iyengar S, Grimm C, Yang M, Ryan ND, Keller MB. Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. Journal of Clinical Psychiatry 2008; 69:1953-1959.
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder. Journal of Clinical Psychiatry 2009; 70:1078-1090.
Goldstein BI, Fagiolini A, Houck PR, Kupfer DJ. Prevalence and correlates of cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders 2009; 11:657-662.
Goldstein BI, Bukstein OG. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. Journal of Clinical Psychiatry 2010; 71:348-358.
Goldstein BI, Shamseddeen W, Axelson DA, Kalas C, Monk K, Brent DA, Kupfer DJ, Birmaher B. Clinical, demographic, and familial correlates of bipolar spectrum disorders among school-aged offspring of parents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010; 49:388-396.
Goldstein BI. Pediatric bipolar disorder: more than a temper problem. Pediatrics 2010; 125:1283-1285.